Desq Long
Sign in

Company

Adaptive Biotechnologies Corp

ADPT · CIK 0001478320

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 21, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001780664-26-000043 · filed 2026-10-21 · View filing →

SEC FORM 4
$151,474.75

Adaptive Biotechnologies Corp (ADPT)

Sale of 5,999 shares at $25.25 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001780664-26-000043 · filed 2026-10-21 · View filing →

SEC FORM 4
$150,402.74

Adaptive Biotechnologies Corp (ADPT)

Sale of 5,882 shares at $25.57 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001780664-26-000043 · filed 2026-10-21 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001780664-26-000043 · filed 2026-10-21 · View filing →

SEC FORM 4
$288,987.93

Adaptive Biotechnologies Corp (ADPT)

Sale of 11,781 shares at $24.53 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001780664-26-000043 · filed 2026-10-21 · View filing →

SEC FORM 4
$2,485.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 100 shares at $24.85 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001780664-26-000043 · filed 2026-10-21 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001780664-26-000043 · filed 2026-10-21 · View filing →

SEC FORM 4
$285,738.05

Adaptive Biotechnologies Corp (ADPT)

Sale of 11,881 shares at $24.05 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001780664-26-000043 · filed 2026-10-21 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 16, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001780664-26-000041 · filed 2026-10-16 · View filing →

SEC FORM 4
$280,376.01

Adaptive Biotechnologies Corp (ADPT)

Sale of 11,581 shares at $24.21 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001780664-26-000041 · filed 2026-10-16 · View filing →

SEC FORM 4
$7,635.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 300 shares at $25.45 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001780664-26-000041 · filed 2026-10-16 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001780664-26-000041 · filed 2026-10-16 · View filing →

SEC FORM 4
$304,272.41

Adaptive Biotechnologies Corp (ADPT)

Sale of 11,881 shares at $25.61 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001780664-26-000041 · filed 2026-10-16 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001780664-26-000041 · filed 2026-10-16 · View filing →

SEC FORM 4
$173,390.17

Adaptive Biotechnologies Corp (ADPT)

Sale of 6,781 shares at $25.57 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001780664-26-000041 · filed 2026-10-16 · View filing →

SEC FORM 4
$131,682.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 5,100 shares at $25.82 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001780664-26-000041 · filed 2026-10-16 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 13, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001780664-26-000039 · filed 2026-10-13 · View filing →

SEC FORM 4
$302,965.50

Adaptive Biotechnologies Corp (ADPT)

Sale of 11,881 shares at $25.50 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001780664-26-000039 · filed 2026-10-13 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001780664-26-000039 · filed 2026-10-13 · View filing →

SEC FORM 4
$232,738.35

Adaptive Biotechnologies Corp (ADPT)

Sale of 9,181 shares at $25.35 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001780664-26-000039 · filed 2026-10-13 · View filing →

SEC FORM 4
$70,389.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 2,700 shares at $26.07 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001780664-26-000039 · filed 2026-10-13 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001780664-26-000039 · filed 2026-10-13 · View filing →

SEC FORM 4
$313,777.21

Adaptive Biotechnologies Corp (ADPT)

Sale of 11,881 shares at $26.41 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001780664-26-000039 · filed 2026-10-13 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 8, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001780664-26-000037 · filed 2026-10-08 · View filing →

SEC FORM 4
$304,866.46

Adaptive Biotechnologies Corp (ADPT)

Sale of 11,881 shares at $25.66 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001780664-26-000037 · filed 2026-10-08 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001780664-26-000037 · filed 2026-10-08 · View filing →

SEC FORM 4
$313,658.40

Adaptive Biotechnologies Corp (ADPT)

Sale of 11,881 shares at $26.40 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001780664-26-000037 · filed 2026-10-08 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 6, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001780664-26-000037 · filed 2026-10-08 · View filing →

SEC FORM 4
$256,664.16

Adaptive Biotechnologies Corp (ADPT)

Sale of 9,381 shares at $27.36 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001780664-26-000037 · filed 2026-10-08 · View filing →

SEC FORM 4
$31,031.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 1,100 shares at $28.21 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001780664-26-000037 · filed 2026-10-08 · View filing →

SEC FORM 4
$26,768.71

Adaptive Biotechnologies Corp (ADPT)

Sale of 901 shares at $29.71 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001780664-26-000037 · filed 2026-10-08 · View filing →

SEC FORM 4
$15,234.47

Adaptive Biotechnologies Corp (ADPT)

Sale of 499 shares at $30.53 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001780664-26-000037 · filed 2026-10-08 · View filing →

SEC FORM 4
$193,320.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 6,444 shares at $30.00 per share.

Reporting Person BOBULSKY SUSAN · Officer Title Chief Commercial Officer, MRD · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001820885-26-000025 · filed 2026-10-08 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 5, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780664-26-000035 · filed 2026-10-05 · View filing →

SEC FORM 4
$193,065.18

Adaptive Biotechnologies Corp (ADPT)

Sale of 6,699 shares at $28.82 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780664-26-000035 · filed 2026-10-05 · View filing →

SEC FORM 4
$153,749.94

Adaptive Biotechnologies Corp (ADPT)

Sale of 5,182 shares at $29.67 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780664-26-000035 · filed 2026-10-05 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780664-26-000035 · filed 2026-10-05 · View filing →

SEC FORM 4
$334,212.53

Adaptive Biotechnologies Corp (ADPT)

Sale of 11,881 shares at $28.13 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780664-26-000035 · filed 2026-10-05 · View filing →

SEC FORM 4
$68,001.48

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 8,038 shares at $8.46 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code M

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780660-26-000024 · filed 2026-10-05 · View filing →

SEC FORM 4
$37,414.23

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 9,377 shares at $3.99 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code M

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780660-26-000024 · filed 2026-10-05 · View filing →

SEC FORM 4
$76,141.24

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 9,377 shares at $8.12 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code M

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780660-26-000024 · filed 2026-10-05 · View filing →

SEC FORM 4
$222,746.88

Adaptive Biotechnologies Corp (ADPT)

Sale of 8,094 shares at $27.52 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780660-26-000024 · filed 2026-10-05 · View filing →

SEC FORM 4
$534,949.78

Adaptive Biotechnologies Corp (ADPT)

Sale of 18,698 shares at $28.61 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780660-26-000024 · filed 2026-10-05 · View filing →

SEC FORM 4
$144,235.34

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 11,881 shares at $12.14 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code M

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780664-26-000035 · filed 2026-10-05 · View filing →

SEC FORM 4
$167,653.17

Adaptive Biotechnologies Corp (ADPT)

Sale of 6,081 shares at $27.57 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780664-26-000035 · filed 2026-10-05 · View filing →

SEC FORM 4
$165,648.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 5,800 shares at $28.56 per share.

Reporting Person RUBINSTEIN JULIE · Officer Title President and COO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001780664-26-000035 · filed 2026-10-05 · View filing →

SEC FORM 4
$644,524.74

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 53,091 shares at $12.14 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$113,347.08

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 13,398 shares at $8.46 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$62,359.71

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 15,629 shares at $3.99 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$190,349.04

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 23,442 shares at $8.12 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$3,013,186.74

Adaptive Biotechnologies Corp (ADPT)

Sale of 107,537 shares at $28.02 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$224,817.33

Adaptive Biotechnologies Corp (ADPT)

Sale of 7,869 shares at $28.57 per share.

Reporting Person LO FRANCIS · Officer Title Chief People Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001780660-26-000022 · filed 2026-09-18 · View filing →

SEC FORM 4
$32,265.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 1,195 shares at $27.00 per share.

Reporting Person BOBULSKY SUSAN · Officer Title Chief Commercial Officer, MRD · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001820885-26-000023 · filed 2026-09-17 · View filing →

SEC FORM 4
$249,990.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 9,615 shares at $26.00 per share.

Reporting Person OWEN KATEY EINTERZ · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001852578-26-000005 · filed 2026-08-28 · View filing →

SEC FORM 4
$94,800.00

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 15,000 shares at $6.32 per share.

Reporting Person HERSHBERG ROBERT · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001274139-26-000004 · filed 2026-08-20 · View filing →

SEC FORM 4
$365,850.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 15,000 shares at $24.39 per share.

Reporting Person HERSHBERG ROBERT · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001274139-26-000004 · filed 2026-08-20 · View filing →

SEC FORM 4
$382,358.24

Adaptive Biotechnologies Corp (ADPT)

Sale of 15,664 shares at $24.41 per share.

Reporting Person HERSHBERG ROBERT · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001274139-26-000004 · filed 2026-08-20 · View filing →

SEC FORM 4
$1,825,327.80

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 278,676 shares at $6.55 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$6,816,994.56

Adaptive Biotechnologies Corp (ADPT)

Sale of 278,472 shares at $24.48 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$5,128.56

Adaptive Biotechnologies Corp (ADPT)

Sale of 204 shares at $25.14 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$94,800.00

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 15,000 shares at $6.32 per share.

Reporting Person NEUPERT PETER M · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001237566-26-000003 · filed 2026-08-19 · View filing →

SEC FORM 4
$378,450.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 15,000 shares at $25.23 per share.

Reporting Person NEUPERT PETER M · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001237566-26-000003 · filed 2026-08-19 · View filing →

SEC FORM 4
$1,004,000.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 40,000 shares at $25.1 per share.

Reporting Person NEUPERT PETER M · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001237566-26-000003 · filed 2026-08-19 · View filing →

SEC FORM 4
$1,753,400.40

Adaptive Biotechnologies Corp (ADPT)

Sale of 69,690 shares at $25.16 per share.

Reporting Person NEUPERT PETER M · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001237566-26-000003 · filed 2026-08-19 · View filing →

SEC FORM 4
$2,104,672.20

Adaptive Biotechnologies Corp (ADPT)

Acquisition (code M) of 321,324 shares at $6.55 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$7,995,478.92

Adaptive Biotechnologies Corp (ADPT)

Sale of 318,799 shares at $25.08 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$64,564.25

Adaptive Biotechnologies Corp (ADPT)

Sale of 2,525 shares at $25.57 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$75,000.00

Adaptive Biotechnologies Corp (ADPT)

Sale of 3,000 shares at $25.00 per share.

Reporting Person BOBULSKY SUSAN · Officer Title Chief Commercial Officer, MRD · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001820885-26-000020 · filed 2026-08-12 · View filing →